Developer of Na-Nose, which can sniff out cancer, proposes linking his groundbreaking diagnostic nanotechnology to a smartphone.
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
BrainStorm’s NurOwn enhanced adult stem cells seem to halt the progression of incurable neurodegenerative diseases.
Octava Pink, a groundbreaking achievement in cancer detection, follows eight years of research at EventusDx in Jerusalem.
Cellect’s stem-cell selection kit could make bone-marrow transplants as low-risk as getting your appendix out.
Notal Vision’s ForeseeHome, invented and made in Israel, allows critical at-home daily monitoring of a disease that can quickly lead to vision loss.
ABC medical drama introduces viewers to RealView Imaging’s futuristic 3D holographic imaging system for heart surgery.
Israel’s RDD Pharma is developing novel therapeutics for gastro and anorectal disorders people are embarrassed to discuss with their doctors.
New disruptive technology developed by Israeli startup Azure PCR could make diagnosis of illness – whether it’s viral, bacterial or even fungal – instant.